Article Text
PostScript
Correspondence
Increasing smokers' risk perception improves CT screening participation
Statistics from Altmetric.com
Footnotes
Funding RPY, and the funding of his research, has been supported by grants from the University of Auckland, Health Research Council of New Zealand and Synergenz BioSciences Ltd. Synergenz BioSciences Ltd holds patents for gene-based risk testing for lung cancer susceptibility.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.